| UniProt ID | TADA3_HUMAN | |
|---|---|---|
| UniProt AC | O75528 | |
| Protein Name | Transcriptional adapter 3 | |
| Gene Name | TADA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 432 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex. Also known as a coactivator for p53/TP53-dependent transcriptional activation. Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4.. | |
| Protein Sequence | MSELKDCPLQFHDFKSVDHLKVCPRYTAVLARSEDDGIGIEELDTLQLELETLLSSASRRLRVLEAETQILTDWQDKKGDRRFLKLGRDHELGAPPKHGKPKKQKLEGKAGHGPGPGPGRPKSKNLQPKIQEYEFTDDPIDVPRIPKNDAPNRFWASVEPYCADITSEEVRTLEELLKPPEDEAEHYKIPPLGKHYSQRWAQEDLLEEQKDGARAAAVADKKKGLMGPLTELDTKDVDALLKKSEAQHEQPEDGCPFGALTQRLLQALVEENIISPMEDSPIPDMSGKESGADGASTSPRNQNKPFSVPHTKSLESRIKEELIAQGLLESEDRPAEDSEDEVLAELRKRQAELKALSAHNRTKKHDLLRLAKEEVSRQELRQRVRMADNEVMDAFRKIMAARQKKRTPTKKEKDQAWKTLKERESILKLLDG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 21 | Sumoylation | FKSVDHLKVCPRYTA CCCCCCCEECCCCEE | 38.07 | - | |
| 21 | Acetylation | FKSVDHLKVCPRYTA CCCCCCCEECCCCEE | 38.07 | 26051181 | |
| 21 | Sumoylation | FKSVDHLKVCPRYTA CCCCCCCEECCCCEE | 38.07 | 28112733 | |
| 26 | Phosphorylation | HLKVCPRYTAVLARS CCEECCCCEEEEEEC | 5.56 | 18452278 | |
| 26 (in isoform 2) | Phosphorylation | - | 5.56 | - | |
| 27 (in isoform 2) | Phosphorylation | - | 16.15 | - | |
| 27 | Phosphorylation | LKVCPRYTAVLARSE CEECCCCEEEEEECC | 16.15 | 18452278 | |
| 33 (in isoform 2) | Phosphorylation | - | 39.51 | - | |
| 33 | Phosphorylation | YTAVLARSEDDGIGI CEEEEEECCCCCCCH | 39.51 | 18452278 | |
| 85 | Methylation | KGDRRFLKLGRDHEL CCCHHHHHCCCCCCC | 46.30 | 115980241 | |
| 103 | Acetylation | PKHGKPKKQKLEGKA CCCCCCCCCCCCCCC | 62.28 | 26051181 | |
| 109 | Acetylation | KKQKLEGKAGHGPGP CCCCCCCCCCCCCCC | 41.65 | 25953088 | |
| 122 | Acetylation | GPGPGRPKSKNLQPK CCCCCCCCCCCCCCC | 73.10 | 26051181 | |
| 124 | Acetylation | GPGRPKSKNLQPKIQ CCCCCCCCCCCCCCE | 68.73 | 26051181 | |
| 129 | Ubiquitination | KSKNLQPKIQEYEFT CCCCCCCCCEEEECC | 44.02 | - | |
| 129 | Sumoylation | KSKNLQPKIQEYEFT CCCCCCCCCEEEECC | 44.02 | 28112733 | |
| 133 | Phosphorylation | LQPKIQEYEFTDDPI CCCCCEEEECCCCCC | 10.44 | 28796482 | |
| 147 | Ubiquitination | IDVPRIPKNDAPNRF CCCCCCCCCCCCCCC | 66.15 | - | |
| 147 | Acetylation | IDVPRIPKNDAPNRF CCCCCCCCCCCCCCC | 66.15 | 113666009 | |
| 187 | Phosphorylation | PEDEAEHYKIPPLGK CHHHHHHCCCCCCCH | 11.34 | 28796482 | |
| 194 | Ubiquitination | YKIPPLGKHYSQRWA CCCCCCCHHHHHHHH | 47.23 | - | |
| 194 | Acetylation | YKIPPLGKHYSQRWA CCCCCCCHHHHHHHH | 47.23 | 113666007 | |
| 210 | Ubiquitination | EDLLEEQKDGARAAA HHHHHHHHHHHHHHH | 62.50 | - | |
| 222 | Ubiquitination | AAAVADKKKGLMGPL HHHHHCHHCCCCCCC | 53.25 | - | |
| 222 | Acetylation | AAAVADKKKGLMGPL HHHHHCHHCCCCCCC | 53.25 | 113666005 | |
| 223 | Ubiquitination | AAVADKKKGLMGPLT HHHHCHHCCCCCCCC | 64.12 | - | |
| 243 | Ubiquitination | DVDALLKKSEAQHEQ HHHHHHHHHHHHHCC | 54.20 | - | |
| 275 | Phosphorylation | LVEENIISPMEDSPI HHHCCCCCCCCCCCC | 17.88 | 20873877 | |
| 280 | Phosphorylation | IISPMEDSPIPDMSG CCCCCCCCCCCCCCC | 16.06 | 30278072 | |
| 286 | Phosphorylation | DSPIPDMSGKESGAD CCCCCCCCCCCCCCC | 54.84 | 20873877 | |
| 290 | Phosphorylation | PDMSGKESGADGAST CCCCCCCCCCCCCCC | 42.65 | 23663014 | |
| 296 | Phosphorylation | ESGADGASTSPRNQN CCCCCCCCCCCCCCC | 34.64 | 29255136 | |
| 297 | Phosphorylation | SGADGASTSPRNQNK CCCCCCCCCCCCCCC | 42.06 | 23401153 | |
| 298 | Phosphorylation | GADGASTSPRNQNKP CCCCCCCCCCCCCCC | 21.26 | 29255136 | |
| 298 (in isoform 2) | Phosphorylation | - | 21.26 | - | |
| 304 | Acetylation | TSPRNQNKPFSVPHT CCCCCCCCCCCCCCC | 37.36 | 26051181 | |
| 307 | Phosphorylation | RNQNKPFSVPHTKSL CCCCCCCCCCCCHHH | 43.18 | 26074081 | |
| 311 | Phosphorylation | KPFSVPHTKSLESRI CCCCCCCCHHHHHHH | 19.09 | 26074081 | |
| 312 | Acetylation | PFSVPHTKSLESRIK CCCCCCCHHHHHHHH | 50.43 | 113666011 | |
| 330 | Phosphorylation | IAQGLLESEDRPAED HHHCCHHCCCCCCCC | 44.78 | 24732914 | |
| 338 | Phosphorylation | EDRPAEDSEDEVLAE CCCCCCCCHHHHHHH | 38.15 | 30266825 | |
| 354 | Ubiquitination | RKRQAELKALSAHNR HHHHHHHHHHHCCCC | 38.49 | - | |
| 354 | Methylation | RKRQAELKALSAHNR HHHHHHHHHHHCCCC | 38.49 | 115980233 | |
| 372 | Ubiquitination | HDLLRLAKEEVSRQE HHHHHHHHHHHHHHH | 60.03 | - | |
| 377 | Methylation | LAKEEVSRQELRQRV HHHHHHHHHHHHHHH | 38.89 | 24395461 | |
| 381 | Methylation | EVSRQELRQRVRMAD HHHHHHHHHHHHHHH | 22.85 | 24395469 | |
| 404 | Acetylation | KIMAARQKKRTPTKK HHHHHHHHCCCCCHH | 38.37 | 7289879 | |
| 410 | Acetylation | QKKRTPTKKEKDQAW HHCCCCCHHHHHHHH | 61.20 | 7289889 | |
| 418 | Acetylation | KEKDQAWKTLKERES HHHHHHHHHHHHHHH | 47.17 | 19608861 | |
| 425 | Phosphorylation | KTLKERESILKLLDG HHHHHHHHHHHHHCC | 39.17 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TADA3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TADA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TADA3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-418, AND MASS SPECTROMETRY. | |